Identification of metastatic papillary thyroid carcinoma in FNA specimens using thyroid peroxidase immunohistochemistry

被引:9
|
作者
Shield, P. W. [1 ,2 ]
Crouch, S. J. [3 ]
Papadimos, D. J. [1 ,3 ]
Walsh, M. D. [3 ]
机构
[1] Queensland Univ Technol, Sch Biomed Sci, Brisbane, Qld, Australia
[2] Sullivan Nicolaides Pathol, Cytol Dept, Brisbane, Qld, Australia
[3] Sullivan Nicolaides Pathol, Histopathol Dept, Brisbane, Qld, Australia
关键词
cytology; fine needle aspiration; immunohistochemistry; metastatic; thyroid papillary carcinoma; thyroid peroxidase; FINE-NEEDLE-ASPIRATION; TRANSCRIPTION FACTOR-I; LYMPH-NODE METASTASES; DIFFERENTIAL-DIAGNOSIS; THYROGLOBULIN; CANCER; CYTOLOGY; TUMORS; GALECTIN-3; PITFALL;
D O I
10.1111/cyt.12531
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
IntroductionWe evaluated immunohistochemical staining for thyroid peroxidase (TPO), a glycoprotein found in the apical plasma membrane of thyroid follicular cells, as a marker for metastatic PTC in FNA samples and compared results with thyroglobulin (Tg) and thyroid transcription factor 1 (TTF1) staining. MethodsCell block sections prepared from 100 FNA specimens were stained with a rabbit monoclonal antibody to TPO (EP159). The FNAs included 64 metastatic malignancies from non-thyroid primary sites, including 18 lung, and 36 cases of thyroid tumours (29 PTC, six cases of medullary thyroid carcinoma and one thyroid anaplastic carcinoma). Thyroid tumours were stained with TTF1 and Tg in addition to TPO. All cases of metastatic lung carcinoma also had TTF-1 staining results. ResultsTPO staining was negative in all non-thyroid malignancies. Ninety percent (26/29) of PTC were positive. All positive cases showed strong cytoplasmic staining, although 54% (14/26) showed positivity in less than half of the cells. By comparison, Tg staining of TPC cases was present in 62% and TTF-1 in 100%. In addition to showing higher sensitivity, interpretation of staining results with TPO was generally easier with than Tg. All metastatic lung adenocarcinomas were positive for TTF-1 and TPO negative. The six medullary cancers showed positivity in 17%, 0% and 83% with TPO, Tg and TTF-1, respectively. ConclusionsTPO (mAb EP159) may be a useful addition to immunohistochemical panels for FNA specimens where metastatic PTC is a consideration, particularly in cases where metastatic lung carcinoma features in the differential diagnosis. Ninety percent of metastatic papillary thyroid carcinomas in cell block specimens from lymph node aspirates were positive for thyroid peroxidase. This was more sensitive than thyroglobulin and more specific than TTF-1, which also stained all metastatic lung adenocarcinomas.
引用
收藏
页码:227 / 232
页数:6
相关论文
共 50 条
  • [21] Diagnostic significance of elevated expression of HBME-1 in papillary thyroid carcinoma
    Chen, Yang-Jing
    Zhao, Rui-Min
    Zhao, Qian
    Li, Bai-Ya
    Ma, Qing-Yong
    Li, Xiao
    Chen, Xia
    TUMOR BIOLOGY, 2016, 37 (07) : 8715 - 8720
  • [22] Significance of CK19, TPO, and HBME-1 expression for diagnosis of papillary thyroid carcinoma
    Liu, Zeming
    Yu, Pan
    Xiong, Yiquan
    Zeng, Wen
    Li, Xiaoyu
    Maiaiti, Yusufu
    Wang, Shuntao
    Song, Haiping
    Shi, Lan
    Liu, Chunping
    Cheng, Bo
    Zhang, Bo
    Ming, Jie
    Dong, Fang
    Ge, Hui
    Nie, Xiu
    Huang, Tao
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (03): : 4369 - 4374
  • [23] Immunohistochemical loss of thyroid peroxidase in papillary thyroid carcinoma: Strong suppression of peroxidase gene expression
    Tanaka, T
    Umeki, K
    Yamamoto, I
    Sugiyama, S
    Noguchi, S
    Ohtaki, S
    JOURNAL OF PATHOLOGY, 1996, 179 (01): : 89 - 94
  • [24] Thyroglobulin measurements in fine-needle aspiration cytology of lymph nodes for the detection of metastatic papillary thyroid carcinoma
    Li, Qing Kay
    Nugent, Summer L.
    Straseski, Joely
    Cooper, David
    Riedel, Stefan
    Askin, Frederic B.
    Sokoll, Lori J.
    CANCER CYTOPATHOLOGY, 2013, 121 (08) : 440 - 448
  • [25] Diagnostic utility of CD56 immunohistochemistry in papillary carcinoma of the thyroid
    El Demellawy, Dina
    Nasr, Ahmed Lotfy
    Babay, Slim
    Alowami, Salem
    PATHOLOGY RESEARCH AND PRACTICE, 2009, 205 (05) : 303 - 309
  • [26] Regional metastatic pattern of papillary thyroid carcinoma
    Yuce, Imdat
    Cagli, Sedat
    Bayram, Ali
    Karasu, Fatih
    Guney, Ercihan
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2010, 267 (03) : 437 - 441
  • [27] Management dilemma in metastatic papillary thyroid carcinoma
    Patel, Cheerag Bharatbhai
    Ahmadi, Omid
    de Groot, Charles
    Sanders, James
    NEW ZEALAND MEDICAL JOURNAL, 2022, 135 (1556) : 127 - 131
  • [28] Combined immunohistochemistry for thyroid peroxidase, galectin-3, CK19 and HBME-1 in differential diagnosis of thyroid tumors
    Paunovic, Ivan
    Isic, Tijana
    Havelka, Marija
    Tatic, Svetislav
    Cvejic, Dubravka
    Savin, Svetlana
    APMIS, 2012, 120 (05) : 368 - 379
  • [29] Metastatic Papillary Thyroid Carcinoma Gone Wild
    Talpur, Khulood
    Soomro, Ambreen
    Talpur, Afrah
    JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2023, 13 (03) : 121 - 125
  • [30] Immunohistochemistry Helps to Distinguish Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features/Noninvasive Encapsulated Follicular Variant of Papillary Thyroid Carcinoma with Other Follicular Thyroid Lesions
    Chuang, Hao-Wen
    Wang, Jyh-Seng
    Tsai, Jen-Wei
    Hsu, Chao-Tien
    Lin, Kai-Jen
    MEDICINA-LITHUANIA, 2021, 57 (11):